FTC Sues Hims & Hers Health as Top-Performing Healthcare Stocks Continue to Rise
The Federal Trade Commission (FTC) is suing Hims & Hers Health over alleged deceptive business practices, but investors shouldn't panic. In related news, several healthcare stocks are drawing attention due to their high trading volume and potential growth.
Eli Lilly and Company, Doximity, Johnson & Johnson, UnitedHealth Group, McKesson, Thermo Fisher Scientific, and AbbVie are among the top-performing healthcare stocks. These companies offer a range of products and services, including pharmaceuticals, medical devices, and health insurance.
Hims & Hers Health has been accused of making false claims about its erectile dysfunction treatment. However, the company's business model may still be successful even if the allegations are true. Hims & Hers offers affordable and convenient healthcare options to customers, which could be a major advantage in the market.